Cerebral Vasospasm

1. Advances in vasospasm research
M. Murray, Nicholas W. C. Dorsch

2. Pre-vasospasm: early brain injury
J. Cahill, John H. Zhang

3. Apoptotic markers in vasospasm after an experimental subarachnoid haemorrhage
J. Cahill, I. Solaroglu, John H. Zhang

4. Cerebrospinal fluid soluble Fas and Fas ligand levels after aneurysmal subarachnoid haemorrhage
Ali Metin Kafadar, M. Uzan, T. Tanriverdi, G. Z. Sanus, H. Uzun, M. Y. Kaynar, C. Kuday

5. Time course of oxyhemoglobin induces apoptosis in mice brain cells in vivo
Wei Shi, L. Y. Huang, R. Z. Wang, J. J. Sun, F. R. Wang, C. X. Liu, L. Zhou, J. H. Zhang

6. Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis
H. Yatsushige, M. Yamaguchi-Okada, C. Zhou, J. W. Calvert, J. Cahill, A. R. T. Colohan, John H. Zhang

7. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm
R. E. Ayer, J. H. Zhang

8. Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics
W. L. Wurster, G. J. Pyne-Geithman, I. R. Peat, Joseph F. Clark

9. Vascular contractility changes due to vasospasm induced by periarterial whole blood and thrombocyte rich plasma
Goksin Sengul, H. H. Kadioglu

10. Vasospasm biochemistry
Shigeru Nishizawa

11. The roles of cross-talk mechanisms in the signal transduction systems in the pathophysiology of the cerebral vasospasm after subarachnoid haemorrhage — what we know and what we do not know
Shigeru Nishizawa, M. Koide, M. Yamaguchi-Okada

12. Subarachnoid hemorrhage induces upregulation of vascular receptors and reduction in rCBF via an ERK1/2 mechanism
Saema Ansar, J. Hansen-Schwartz, L. Edvinsson

13. Effect of deferoxamine-activated hypoxia inducible factor-1 on the brainstem following subarachnoid haemorrhage
S. Ono, Tomohito Hishikawa, T. Ogawa, M. Nishiguchi, K. Onoda, K. Tokunaga, K. Sugiu, I. Date

14. Urgosedin downregulates mRNA expression of TNF-a in brain tissue of rats subjected to experimental subarachnoid haemorrhage
S. -C. Chen, S. -C. Wu, Y. -C. Lo, S. -Y. Huang, W. Winardi, D. Winardi, I. -J. Chen, S. -L. Howng, Aij-Lie Kwan

15. Nucleotide-induced cerebral vasospasm in an in vivo mouse model
Anthony Jabre, A. Patel, L. Macyszyn, D. Taylor, M. Keady, Y. Bao, J. -F. Chen

16. Effects of ADPbetaS on purine receptor expression in mouse cerebral vasculature
Anthony Jabre, L. Macyszyn, M. Keady, Y. Bao, A. Patel, J. -F. Chen

17. Electrophysiology of cerebral vasospasm
A. Kawashima, R. Loch Macdonald

18. Cellular basis of vasospasm: role of small diameter arteries and voltage-dependent Ca2+ channels
M. Ishiguro, George C. Wellman

19. Acute and chronic effects of oxyhemoglobin on voltage-dependent ion channels in cerebral arteries
M. Ishiguro, K. Murakami, T. Link, K. Zvarova, B. I. Tranmer, A. D. Morielli, George C. Wellman

20. The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat
D. Hänggi, B. Turowski, J. Perrin, M. Rapp, J. Liersch, M. Sabel, H. -J. Steiger

21. Cerebral vasospasm following subarachnoid haemorrhage is completely prevented by L-type calcium channel antagonist in human
H. Kasuya, H. Onda, B. Krischek, T. Hori

22. Vasospasm pharmacology
Hartmut Vatter, V. Seifert

23. Endothelin-converting enzyme inhibitor versus cerebrovasospasm
W. Winardi, A. L. Kwan, C. L. Lin, A. Y. Jeng, K. I. Cheng

24. A pharmacokinetic study of clazosentan in patients with aneurysmal subarachnoid haemorrhage
P. L. M. Giersbergen, P. Vajkoczy, B. Meyer, S. Weidauer, A. Raabe, C. Thome, F. Ringel, V. Breu, P. Schmiedek, Jasper Dingemanse

25. Pharmacokinetic and pharmacodynamic aspects of the interaction between clazosentan and nimodipine in healthy subjects
P. L. M. Giersbergen, Jasper Dingemanse

26. Attenuation of intercellular adhesion molecule-1 and cerebral vasospasm in rabbits subjected to experimental subarachnoid haemorrhage by CGS 26303
C. L. Lin, K. I. Cheng, D. Winardi, K. S. Chu, S. C. Wu, S. I. Lue, D. I. Chen, C. S. Liu, A. Y. Jeng, A. L. Kwan

27. The effect of 17ß-estradiol in the prevention of cerebral vasospasm and endothelin-1 production after subarachnoid haemorrhage
Y. F. Su, C. L. Lin, A. S. Lieu, K. S. Lee, C. J. Wang, C. Z. Chang, T. F. Chan, K. I. Cheng, S. L. Howng, A. L. Kwan

28. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH
Ryszard M. Pluta

29. An adenosine A1 receptor agonist preserves eNOS expression and attenuates cerebrovasospasm after subarachnoid haemorrhage
C. L. Lin, C. Z. Chang, Y. F. Su, A. S. Lieu, K. S. Lee, J. K. Loh, T. F. Chan, C. J. Wang, S. L. Howng, A. L. Kwan

30. Gene transfer after subarachnoid hemorrhage: a tool and potential therapy
Donald D. Heistad, Y. Watanabe, Y. Chu

31. Direct protein transduction method to cerebral arteries by using 11R: new strategy for the treatment of cerebral vasospasm after subarachnoid haemorrhage
Tomoyuki Ogawa, S. Ono, T. Ichikawa, H. Michiue, S. Arimitsu, K. Onoda, K. Tokunaga, K. Sugiu, K. Tomizawa, H. Matsui, I. Date

32. Endothelial nitric oxide synthase-11R protein therapy for prevention of cerebral vasospasm in rats: a preliminary report
Tomoyuki Ogawa, S. Ono, T. Ichikawa, S. Arimitsu, K. Onoda, K. Tokunaga, K. Sugiu, K. Tomizawa, H. Matsui, I. Date

33. Microarray analysis of hemolysate-induced differential gene expression in cultured human vascular smooth muscle cells (HVSMC)
T. Sasaki, Hidetoshi Kasuya, Y. Aihara, T. Hori

34. Role of vascular remodeling in cerebral vasospasm
Hiroki Ohkuma, A. Munakata, S. Suzuki

35. Possible role of tenascin-C in cerebral vasospasm after aneurysmal subarachnoid haemorrhage
Hidenori Suzuki, K. Kanamaru, Y. Suzuki, Y. Aimi, N. Matsubara, T. Araki, M. Takayasu, T. Takeuchi, K. Okada, N. Kinoshita, K. Imanaka-Yoshida, T. Yoshida, W. Taki

36. Ecdysterone-sensitive smooth muscle cell proliferation stimulated by conditioned medium of endothelial cells cultured with bloody cerebrospinal fluid
Z. Chen, G. Zhu, J. H. Zhang, Z. Liu, W. Tang, Hua Feng

37. The effect of oxyhemoglobin on the proliferation and migration of cultured vascular advential fibroblasts
W. -H. Tang, G. Zhu, J. H. Zhang, Z. Chen, Z. Liu, Hua Feng

38. The effect of oxyhemoglobin on the proliferation and migration of cultured vascular smooth muscle cells
W. -H. Tang, G. Zhu, J. H. Zhang, Z. Chen, Z. Liu, Hua Feng

39. Comparison of three measurement methods for basilar artery with neurological changes in rabbits subjected to experimental subarachnoid hemorrhage
J. R. Kuo, C. P. Yen, S. C. Wu, Y. F. Su, S. L. Howng, A. L. Kwan, A. Y. Jeng, W. Winardi, N. F. Kassell, Chih-Zen Chang

40. Vasospasm diagnosis strategies
Peter Vajkoczy, E. Münch

41. Continuous evaluation of regional oxygen saturation in cerebral vasospasm after subarachnoid haemorrhage using INVOS®, portable near infrared spectrography
Shigeki Ono, S. Arimitsu, T. Ogawa, H. Manabe, K. Onoda, K. Tokunaga, K. Sugiu, I. Date

42. Automated voxel-based analysis of brain perfusion SPECT for vasospasm after subarachnoid haemorrhage
Satoshi Iwabuchi, T. Yokouchi, H. Terada, M. Hayashi, H. Kimura, A. Tomiyama, Y. Hirata, N. Saito, J. Harashina, H. Nakayama, K. Sato, K. Hamazaki, K. Aoki, H. Samejima, M. Ueda

43. Angiographic scale for evaluation of cerebral vasospasm
Edgar Nathal, F. Lóopez-González, C. Rios

44. CT evaluation of late cerebral infarction after operation for ruptured cerebral aneurysm
Hiroshi Wanifuchi, A. Sasahara, S. Sato

45. Elevated intracranial pressure or subarachnoid blood responsible for reduction in cerebral blood flow after SAH
Saema Ansar, L. Edvinsson

46. Magnetic resonance imaging in the canine double-haemorrhage subarachnoid haemorrhage model
T. Sugawara, A. Wang, V. Jadhav, T. Tsubokawa, A. Obenaus, John H. Zhang

47. Perfusion/diffusion-weighted imaging protocol for the diagnosis of cerebral vasospasm and management of treatment after subarachnoid haemorrhage
Jürgen Beck, A. Raabe, H. Lanfermann, J. Berkefeld, R. Mesnil de Rochemont, F. Zanella, V. Seifert, S. Weidauer

48. Diffusion and perfusion MRI findings with clinical correlation in patients with subarachnoid haemorrhage related vasospasm
Serra Sencer, T. Kiris, A. Sencer, U. Yaka, M. Sahinbas, K. Aydin, B. Tiryaki, A. Karasu, O. Agus, M. Ozkan, M. Imer, F. Unal

49. Correlation of end-tidal CO2 with transcranial Doppler flow velocity is decreased during chemoregulation in delayed cerebral vasospasm after subarachnoid haemorrhage — results of a pilot study
B. Schatlo, S. Gläsker, A. Zauner, G. B. Thompson, E. H. Oldfield, Ryszard Pluta

50. A diagnostic flowchart, including TCD, Xe-CT and angiography, to improve the diagnosis of vasospasm critically affecting cerebral blood flow in patients with subarachnoid haemorrhage, sedated and ventilated
Arturo Chieregato, R. Battaglia, G. Sabia, C. Compagnone, F. Cocciolo, F. Tagliaferri, R. Pascarella, U. Pasquini, M. Frattarelli, L. Targa

51. Basilar artery vasospasm: diagnosis and grading by transcranial Doppler
Gill E. Sviri, M. Zaaroor, G. W. Britz, C. M. Douville, A. Lam, D. W. Newell

52. Predictive value of transcranial Doppler to detect clinical vasospasm in patients with aneurysmal subarachnoid haemorrhage
Meltem Can, O. Kahyaoglu, I. Çolak, Y. Aydin

53. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a meta-analysis of published data
G. K. Wong, W. S. Poon, M. T. V. Chan

54. Hypomagnesemia after ruptured middle cerebral artery aneurysms: predictive factor and pathophysiological implication
G. K. Wong, W. S. Poon, M. T. V. Chan

55. The role of magnesium sulfate in the treatment of vasospasm in patients with spontaneous subarachnoid haemorrhage
Kostas N. Fountas, T. G. Machinis, J. S. Robinson, C. Sevin, N. I. Fezoulidis, M. Castresana, E. Z. Kapsalaki

56. Fasudil (a rho-kinase inhibitor) may specifically increase rCBF in spastic area
Masato Shibuya, A. Ikeda, K. Ohsuka, Y. Yamamoto, S. Satoh

57. Multimodality therapy for cerebral vasospasm after SAH: importance of intensive care and intraarterial injection of fasudil hydrochloride
Shigeki Ono, S. Arimitsu, T. Ogawa, K. Onoda, K. Tokunaga, K. Sugiu, I. Date

58. The effect of KMUVS-1 on experimental subarachnoid haemorrhage-induced cerebrovasospasm
K. -C. Sung, C. -P. Yen, J. -H. Hsu, S. -C. Wu, Y. -C. Wu, S. -I. Lue, W. Winardi, K. -I. Cheng, Aij-Lie Kwan

59. Role of statins in cerebral vasospasm
T. Sugawara, R. Ayer, John H. Zhang

60. Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model
Burçak Bilginer, B. Öal, K. Yigitkanli, F. Söylemezoglu, M. Bavbek, I. M. Ziyal, T. Özgen

61. Ecdysterone attenuates vasospasm following experimental subarachnoid haemorrhage in rabbits
Z. Liu, G. Zhu, J. H. Zhang, Z. Chen, W. -H. Tang, X. -R. Wang, Feng Hua

62. Clot-clearance rate in the sylvian cistern is associated with severity of cerebral vasospasm after subarachnoid haemorrhage
Tomikatsu Toyoda, T. Ohta, T. Kin, T. Tanishima

63. Simultaneous head rotation and lumboventricular lavage in patients after severe subarachnoid haemorrhage: an initial analysis of the influence on clot clearance rate and cerebral vasospasm
Daniel Hänggi, J. Liersch, G. Wöbker, H. -J. Steiger

64. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs
Yutaka Kai, M. Morioka, S. Yano, T. Mizuno, J. -I. Kuratsu, J. -I. Hamada, T. Todaka

65. Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm
Yasuhiko Hayashi, Y. Kai, M. Mohri, N. Uchiyama, J. -I. Hamada

66. Prevention of symptomatic vasospasm — effect of continuous cisternal irrigation with urokinase and ascorbic acid
Namio Kodama, T. Sasaki, M. Matsumoto, K. Suzuki, J. Sakuma, Y. Endo, M. Oinuma, T. Ishikawa, T. Sato

67. Cisternal washing therapy for the prevention of cerebral vasospasm following SAH: analysis of 308 consecutive cases with Fisher group 3 SAH
Tadayoshi Nakagomi, T. Ishii, K. Furuya, H. Nagashima, M. Hirata, A. Tamura

68. Questionable value of decompressive craniectomy after severe aneurysmal subarachnoid haemorrhage
Matthias Jaeger, M. U. Schuhmann, J. Meixensberger

69. Low incidence of cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a comparison between surgical repairs and endovascular coil occlusions
Yoshikazu Yoshino, Y. Takasato, H. Masaoka, T. Hayakawa, N. Otani, H. Yatsushige, T. Sugawara, A. Kitahashi, Y. Obikane, C. Aoyagi

70. Microsurgical treatment of unruptured intracranial aneurysms
Naci Balak, A. Çerçi, A. Serefhan, K. Coskun, R. Sari, N. Isik, I. Elmaci

71. Coil embolization decrease the incidence of symptomatic vasospasm, except in patients with poor grade subarachnoid hemorrhage
Noritaka Aihara, M. Mase, K. Yamada

72. Endovascular therapy of cerebral vasospasm: two year experience with angioplasty and/or intraarterial administration of nicardipine and verapamil
A. L. Delgado, B. Jahromi, N. Müller, H. Farhat, J. Salame, Alois Zauner

73. Utility of intra-arterial nimodipine for cerebral vasospasm
Edgar Nathal, C. García-Perales, A. Lee, R. Ondarza, M. Zenteno

74. Intra-arterial nicardipine successfully relieved post-subarachnoid hemorrhage cerebral vasospasm during aneurysm embolization: a case report
K.- C. Lin, C.-C. Chung, A.- L. Kwan, Y.- L. Kuo, S.- L. Howng, K.- A. Chang, S.- C. Wu, An-Kuo Chou

75. Evaluating the factors affecting cerebral vasospasm in patients after aneurysmal subarachonoid haemorrhage
Mustafa Aziz Hatiboglu, K. Bikmaz, A. C. Iplikcioglu, N. Turgut

76. Is cerebral salt wasting after subarachnoid haemorrhage caused by bleeding?
J. Kojima, Y. Katayama, T. Igarashi, M. Yoneko, K. Itoh, T. Kawamata, T. Mori, N. Moro

77. Relationship between the development of vasospasm after aneurysmal subarachnoid haemorrhage and the levels of dendroaspis natriuretic peptide in body fluids
Alpay Serefhan, N. Balak, A. Çerçi, K. Coskun, R. Sari, G. Silav, N. Isik, M. Çelik, I. Elmaci

78. An abrupt fall in blood pressure in aneurysmal subarachnoid hemorrhage
Sadaharu Tabuchi, N. Hirano, M. Tanabe, K. Akatsuka, T. Watanabe

79. C-reactive protein might predict outcome in aneurysmal subarachnoid haemorrhage
Kostas N. Fountas, M. Kassam, T. G. Machinis, V. G. Dimopoulos, J. S. Robinson, M. Ajjan, A. A. Grigorian, E. Z. Kapsalaki

80. Factors affecting the incidence and severity of vasospasm after subarachnoid haemorrhage
Mustafa Kemal Hamamcioglu, C. Kilincer, E. Altunrende, T. Hicdonmez, O. Simsek, S. Akyel, S. Cobanoglu

81. Basilar artery vasospasm: impact on outcome
Gill E. Sviri, M. Zaaroor, G. W. Britz, C. M. Douville, A. Lam, D. W. Newell

82. Change of management results in good-grade aneurysm patients
Sung-Don Kang

83. Quantification of transient ischemic and metabolic events in patients after subarachnoid haemorrhage
Oliver W. Sakowitz, K. L. Krajewski, D. Haux, B. Orakcioglu, A. W. Unterberg, K. L. Kiening

84. Pediatric subarachnoid haemorrhage
David L. Westra, A. R. T. Colohan

85. Childhood intracranial aneurysms
Altay Sencer, T. Kiris, A. Aydoseli, B. Göker, B. Tatli, A. Karasu, K. Hepgül, N. Izgi, A. Canbolat

86. Pediatric cerebral aneurysms: a report of 9 cases
Mehmet Tatli, A. Guzel, C. Kilincer, H. M. Goksel

87. Intracranial aneurysms during childhood and puberty
A. Mosiewicz, P. Markiewicz, M. Szajner, Tomasz Trojanowski

88. Vasospasm in traumatic brain injury
Sean S. Armin, A. R. T. Colohan, J. H. Zhang

89. Traumatic vasospasm
S. Stein, Peter D. Roux

90. Cerebral vasospasm in diffuse axonal injury patients
Mehdi Farhoudi, A. Zeinali, M. Aghajanloo, M. Asghari

91. The effects of nimopidine on platelet aggregation in severe head injury
Mehmet Tatli, A. Guzel, C. Kilinçer, S. Batun

92. “Street drugs” and subarachnoid haemorrhage
S. Ghostine, Austin Colohan

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: MEDICAL / Public Health MED078000